GlassScriptPhysician profile
Anish Y Parekh
NPI 1831394709
$3,299.17
in general payments reported to CMS, 2019-2025
14 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $225 · 2021: $336 · 2022: $516 · 2023: $643 · 2024: $662 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $754.89 | 2020-2025 | |
| Genzyme Corporation | $646.78 | 2020-2025 | |
| Glaxosmithkline, LLC. | $603.47 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $307.35 | 2021-2025 | Dupixent |
| Optinose US, INC. | $294.43 | 2019-2024 | |
| Medtronic, INC. | $257.25 | 2024-2025 | Propel, Stealthstation S8 Platform, Nuvent |
| Stryker Corporation | $184.93 | 2022-2024 | Scopis Ent |
| Acclarent, INC | $137.88 | 2019-2021 | |
| Ethicon US, LLC | $27.10 | 2022 | |
| Alk-Abello, INC | $19.87 | 2019 | |
| Amgen INC. | $19.23 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $16.50 | 2019 | |
| Aroa Biosurgery Incorporated | $16.31 | 2024 | |
| Novartis Pharmaceuticals Corporation | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anish Parekh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.